`
`United States Court of Appeals
`for the Federal Circuit
`______________________
`
`ALTAIRE PHARMACEUTICALS, INC.,
`Appellant
`
`v.
`
`PARAGON BIOTECK, INC.,
`Appellee
`______________________
`
`2017-1487
`______________________
`
`Appeal from the United States Patent and Trademark
`Office, Patent Trial and Appeal Board in No. PGR2015-
`00011.
`
`______________________
`
`Before O’MALLEY, SCHALL, and WALLACH, Circuit Judges.
`PER CURIAM.
`
`O R D E R
` Upon consideration of the parties’ September 24, 2018
`response to this court’s order to show cause,
`
`IT IS ORDERED THAT:
` We do not typically vacate an issued opinion. Cf. Tivo
`Inc. v. EchoStar Corp., 429 F. App’x 975, 976 (Fed. Cir.
`2011). However, in light of the parties’ settlement in this
`case, the court shall modify the precedential opinion and
`
`
`
`
`
` 2
`
` ALTAIRE PHARM., INC. v. PARAGON BIOTECK, INC.
`
`judgment issued May 2, 2018, by vacating only the por-
`tion that orders remand to the U.S. Patent and Trade-
`mark Office’s Patent Trial and Appeal Board. Any
`citation to our underlying opinion should read: Altaire
`Pharmaceuticals, Inc. v. Paragon Bioteck, Inc., 889 F.3d
`1274 (Fed. Cir. 2018), remand order modified by stipula-
`tion, [this order].
`
`
`
`October 2, 2018 /s/ Peter R. Marksteiner
`
` Date
`
`
`
` Peter R. Marksteiner
`
`
`
`
`
`
` Clerk of Court
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` FOR THE COURT
`
`